Warm needling treatment is a particular form of acupuncture, combining acupuncture together with moxibustion by stimulating acupoints with a burning moxa stick on the handle of the acupuncture needle. Warm needling treatment has a long history in China. Many researchers have explored how acupuncture and moxibustion work and have investigated the change in the body after treatment. Studies have also been performed at the molecular level. For example, acupuncture has been found to induce expression of the FOS gene (for c-Fos) in spinal cord injury [1], the IL1A gene in allergic rhinitis [2] and bone cancer [3] , and heat shock protein 70 in aging rats [4] . More recently, cDNA microarray technology has
been used to target differential expression of genes induced by acupuncture. Kim et al [5] identified gene alterations in animal studies due to electroacupuncture. Li and Zhang [6] found electroacupuncture at the Fenglong acupoint could regulate the expression of genes related to cholesterol metabolism, signal transduction, transcription regulation, the cell cycle, cell adhesion, immunity and stress. Guo et al [7] used cDNA microarray to explore gene expression related to the protective effects of electroacupuncture against cerebral ischemia, finding that major upregulated genes were related to signal transduction, the cell cycle, metabolism, the stress response, and DNA repair. However, these studies have not identified a dominant category of gene, nor has an interaction between these different gene categories been identified.
Acupuncture is an effective treatment for knee osteoarthritis (OA), relieving not only local pain and stiffness but also reducing whole body symptoms [8, 9] . According to the four diagnostic methods of traditional Chinese medicine (TCM), general symptoms of knee OA are mainly manifested by aversion to cold, cold pain and stiffness in the knee joint, huddling up during sleep, relief from pain by warmth or pressure, clear and profuse urine, loose stools, a pale, white furry tongue, and a deep, slow and feeble pulse. These symptoms all belong to the clinical manifestations of deficiency-cold syndrome, which occurs with the highest frequency in knee OA [10] . The view of TCM is that deficiency-cold syndrome is caused by the declined yang-qi and the body's failure to generate heat for warmth. Warm needling treatment could reactivate the yang-qi through moxibustion and needling, thus reducing the deficiency-cold symptoms of knee OA.
The biological mechanisms behind warm needling treatment of the OA patient with deficiency-cold syndrome has not been identified, with the effects of warm needling treatment mostly evaluated using clinical observations [11, 12] . Studies into the genetic background of either OA or deficiency-cold syndrome have been performed. Some genes found to play a role in the development of OA include IL-1, TNF-α, IL-6, TGF-β, matrix metalloproteinases [13−15] , growth arrest and DNA damage-inducible protein 45beta [16] , thrombospondin motifs 5 and apolipoprotein L-I [17] . These genes are mainly involved in cell growth, apoptosis and bone remodeling [18−20] . Gene expression in deficiency-cold syndrome has also been explored, with studies indicating that differentially expressed genes were mainly associated with metabolism-related gene regulation [21−25] . Our preliminary studies also suggested that differential expression of genes between OA patients with deficiency-cold syndrome and controls were mainly associated with metabolism [26] .
Given this observation, we adapted cDNA microarray technology to analyze the molecular mechanisms involved with warm needling treatment.
Materials and Methods

Samples
Ten patients with highly accumulated clinical scores for knee OA of deficiency-cold syndrome were selected from Dabao town, Pengzhou, Sichuan Province, China. Patients were selected according to knee OA diagnostic criteria revised by the United States Rheumatology Institute in 1995, and the classification standard for deficiency-cold syndrome [27, 28] . All patients accepted 2 weeks of warm needling treatment. The peripheral blood was collected from each of them before treatment began and after treatment finished. Only four blood samples of patients showing the greatest efficacy were further processed for cDNA microarray tests.
Diagnosis questionnaire for knee OA of deficiency-cold syndrome
The questionnaire was designed using the comprehensive manifestations of both knee OA and deficiencycold syndrome. The questionnaire was also established with referencing of the World Health Organization's quality of life questionnaire (WHO-100), the America Health Condition Questionnaire (SF-36) and the Western Ontario and McMaster Universities Index of Osteoarthritis [29] . This 40-factor questionnaire was developed and ascertained through the analysis of data collected from epidemiological studies. The 40 factors can be divided into main symptoms (cold pain in knee joint, cold limbs, aversion to cold, curling body up for warmth) and supplementary symptoms (stiffness of the knee joint, cold lumbar pain, clear and copious urine, pale facial complexion, pale tongue, and slow pulse). Each factor was given a qualitative and quantitative score. The qualitative score was graded as 1 for positive and 0 for negative. The quantitative score was graded with a four-point grading system [27] : none, light, medium and severe, which was correspondingly scored as 0, 1, 2, and 3. For example, a quantitative score of 1 was given if the waist and the back occasionally felt cold and no extra clothes or a blanket were required. A score of 2 occurred when the patient often felt cold and needed extra clothes or a quilt. Patients feeling very cold and needing thick clothes or a blanket were given a score of 3. Adding the qualitative and quantitative scores for each main symptom gave the qualitative total score for main symptoms and the quantitative total score for main symptoms, respectively. Total qualitative and quantitative scores for main symptoms were then combined to give qualitative total scores and the quantitative total scores. Total score was derived from the addition of the qualitative total scores and the quantitative total scores.
The total score and the qualitative total score for main symptoms were taken as two indices for the evaluation of deficiency-cold syndrome. A subject with a qualitative total score for main symptoms of at least 2 and total score of at least 40 was regarded as having knee OA of deficiency-cold syndrome. A patient with a qualitative total score for main symptoms of 4 and a total score of at least 50 was selected as typical knee OA of deficiencycold syndrome.
Warm needling treatment
The following acupoints were chosen for warm needling treatment: Guan Yuan (R4), Qi Hai (R6), Zu San Li (ST36; both sides), Xi Yan (EX32; both sides) and Yang Ling Quan (GB34; both sides). The treatment procedure was as follows. The above selected acupoints were stimulated with 40-mm long, 0.35-mm thick needles. When De Qi sensations (mild tingling or aching sensation in the acupuncture point) were obtained, the needles were gently and evenly rotated for 1−2 minutes. A 2-cm ignited moxa stick was then fixed onto the handle of each needle. After one moxa stick burned out, it was replaced by another. This treatment lasted for about 40 minutes. The needles were then removed when cooled. The treatment was repeated daily for 2 weeks. After 2 weeks of treatment, the therapeutic efficacy of warm needling treatment was evaluated.
cDNA microarray test
Leukocytes from samples were harvested from the peripheral blood collected pretreatment and posttreatment. Blood was centrifuged and cells were stored in RNAlater (Ambion Inc., Austin, TX, USA) for further processing. Total RNA was then extracted using Trizol (Invitrogen Life Technologies Inc., Carlsbad, CA, USA) and further purified using Qiagen RNeasy (Qiagen, Valencia, CA, USA) according to the procedures recommended by the manufacturer. Reverse transcription of purified RNA samples (10 μg) was then performed to obtain cDNA. RNA pooled from pretreatment patients was labeled with Cy5 3DNA capture reagent for reference, and the RNA extracted from posttreatment patients was labeled with Cy3 3DNA capture reagent. The labeled samples were hybridized with 21,329 clone spots on a cDNA Spotted Microarray chip (Capital Biochip Co., LTD, Beijing, China). After hybridization and washing steps, image and data analyses were performed. The array was scanned through an ArrayWoRx scanner (Applied Precision Inc., Issaquah, WA, USA) using fluorescent microscopy. Individual images of Cy3 and Cy5 were acquired for each sample. These images were also analyzed using ArrayWoRx software (version 1.5) and their signal intensities were normalized through a scaling factor, such that the average of Cy3/Cy5 across the entire array was 1.0.
Results
Accumulated clinical scores of knee
OA in deficiency-cold syndrome Table 1 shows the pretreatment and posttreatment accumulated clinical scores of four patients with knee OA of deficiency-cold syndrome. Before treatment, all four patients scored a qualitative total score for main symptoms of 4 and scored a total score of 70, 57, 71, and 51, respectively. All patients were classified as typical OA patients of deficiencycold syndrome according to the diagnostic criteria described above. After treatment, their qualitative total scores for main symptoms were reduced to 2 and total scores were also decreased to 12, 18, 17 and 12, respectively, revealing a greater than 65% reduction in total score and 50% reduction in the qualitative total score for main symptoms. These reductions indicate that a positive therapeutic efficacy is achieved with warm needling treatment in the patients with knee OA of deficiency-cold syndrome.
Functional annotation of differentially expressed genes
Fold change analysis [30, 31] was used to identify differentially expressed genes. We arbitrarily set 20% above (upregulated) or below (downregulated) the mean as the range of differentially expressed genes. Such a criterion encompassed a manageable number of genes for further analysis. Using this criterion, 41, 246, 57 and 70 differentially expressed genes were obtained for each patient, respectively. The FatiGO database (see http://babelomics3. bioinfo.cipf.es) was used to identify the biological functions of differentially expressed genes. FatiGO annotation may be divided into three levels: cell components, molecular functions and biological processes. In this study, more attention was paid to genes involved in biological processes, with 36, 45, 27 and 37 differentially expressed genes seen in the four patients that were studied. The majority of genes were involved in cellular metabolic processes (69.23%, 50.38%, 54.55% and 60.47%, respectively) and primary metabolic process (65.38%, 50.09%, 51.52% and 55.81%, respectively). Upregulated and downregulated genes were further entered into the FatiGO database. These genes were still functionally concentrated on cellular and primary metabolic processes, with a greater percentage of genes being upregulated than downregulated (see Table 2 ).
Pathways influenced by differentially expressed genes
The four sets of differentially expressed genes were entered into the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database (see http:// www.genome.jp/kegg/pathway.html). This database revealed 21, 53, 24 and 26 pathways in each patient that may be influenced by the differentially expressed genes. Of these pathways, 6, 19, 8 and 3 pathways were related to metabolism, accounting for 30%, 35.8%, 33.3% and 11.6% of the possible pathways altered in each patient. According to the functional classification of the KEGG database, metabolic pathways could be further subdivided into energy, lipid, carbohydrate, and amino acid metabolism. Table 3 shows this subdivision, with one typical energy metabolism pathway, oxidative phosphorylation, commonly appearing in the results from the four samples.
Discussion
Therapeutic efficacy of warm needling treatment
The clinical manifestations of deficiency-cold syndrome show a lower metabolism state in the body. OA patients usually show these symptoms. Good effects on knee OA have been observed after treatment with acupuncture [9, 32, 33] . Therefore, selected patients diagnosed with knee OA of deficiency-cold syndrome are suitable as study subjects for exploring the molecular mechanisms affected by warm needling treatment. Warm needling treatment was implemented in this research as outlined in the concept of "cryopathy requiring warm prescription" in TCM theory [34] . Warm needling treatment has dual effects of acupuncture and moxibustion. It can positively deliver the heat energy of burning moxa into the deep part of knee joints along the needle body, relieving pain and stiffness in the knee joint and correcting the deficiency-cold condition of the whole body.
Although clinical studies find that warm needling treatment is an effective modality for many kinds of diseases [35] , an objective evaluation of its therapeutic efficacy has not been performed. In our experiment, a questionnaire of knee OA of deficiency-cold syndrome was implemented to capture macro-changes of the syndrome between pretreatment and posttreatment. After treatment, chronic pain and stiffness in the knee were significantly eased. The symptoms of deficiency-cold syndrome were also apparently relieved. As shown in Table 1 , accumulated clinical scores decreased significantly after warm needling treatment. Both qualitative total score for main symptoms and total score for deficiency-cold syndrome apparently decreased in all four patients. This suggests that the therapeutic efficacy of warm needling treatment not only affects one single symptom, but also, and perhaps more importantly, rebalances and harmonizes the whole body.
Blood cell-based gene expression profile changes after warm needling treatment
OA is a disease affecting articular cartilage, joints and bone tissue. Studying biomarkers in this tissue can surely and directly reflect pathological changes of the disease. However, the human body is a whole system, and any disease, including OA, is the result of some disorder in the entire human body. Furthermore, knee OA may mainly associate with deficiencycold syndrome, which is caused by a functional disorder of the whole body. Therefore, using blood cells as the initial samples to perform cDNA microarray studies can reflect the regulatory effects of warm needling treatment on the whole body. In this sense, this report describes a new attempt in the study of OA, exploring the gene expression profile through blood-based cDNA microarray technology.
Chinese treatment aims at regulating overall body function, which may involve the interaction of many genes. cDNA microarray may simultaneously detect up to thousands of genes expressed in one biological sample, which can help determine changes in gene expression profiles in samples obtained post-interference by an external stimulus.
This study describes warm needling treatment as the main external stimulus. Thus, gene expression changes between pre-and post-warm needling treatment may be interpreted as related to therapeutic efficacy. Results demonstrated that differentially expressed genes discovered using cDNA screening were involved in several biological processes such as metabolism and cell communication. Over 50% of these differentially expressed, i.e., upregulated and downregulated, genes were functionally related to cell metabolism and primary metabolism. Notably, upregulated genes represented a higher percentage of differentially expressed genes compared to downregulated genes. These results indicate that warm needling treatment does not only affect the local area of treatment, but also the entire body. The therapeutic efficacy of warm needling treatment can be associated with the regulation of many groups of genes. The regulatory effects on each group of genes are not identical, but are mainly associated with metabolism-related genes, especially cellular metabolism and primary metabolism.
Molecular pathways affected after warm needling treatment
Warm needling treatment has been proven to be effective in rebalancing and harmonizing the whole body [36] . According to TCM theory, nothing in the human body can function independently, as is the case with genes regulated by warm needling treatment. As discussed above, the gene group functionally related to metabolism was prominent following warm needling treatment. Therefore research into these molecular interactions and reaction pathways involved in warm needling treatment are required to determine the biological basis for the efficacy of this treatment. Screening for molecular pathways is a good way to determine these interactions between associated genes and pathways. Based on the categorization of the KEGG database, our results revealed that most of the differentially expressed genes participated in seven types of metabolic pathways. Energy metabolism and carbohydrate metabolism were the two biggest functional types of metabolic pathways in which the majority of genes were involved. Energy metabolism pathways were found to be involved in the differential expression of genes in the cDNA array screens from all four patients. Oxidative phosphorylation, a main step in the production of ATP, an important source of energy, is a typical energy metabolism pathway that was repeatedly found in all patients. Results suggest that warm needling treatment may actually help balance energy metabolism by regulating gene expression involved in energy metabolism pathways.
Conclusions
This study compared the gene expression profile of OA patients of deficiency-cold syndrome pre-and post-warm needling treatment. After further exploring the FATIGO and KEGG databases, most functionally identified genes were found to be related to metabolism, especially cellular and primary metabolic processes. Furthermore, almost all identified pathways were related to metabolism. These results imply that the molecular therapeutic efficacy of warm needling treatment is mainly associated with the regulation of metabolism-related genes and pathways. However, the understanding of this process is still in its infancy and more evidence and further laboratory validation are still required. Our present report may help to further understand warm needling treatment and adds to the accumulating evidence supporting its efficacy.
